Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
National Emergency Tele-Critical Care in a Pandemic: Barriers and Solutions.
Pamplin JC, Gray B, Quinn MT, Little JR, Colombo CJ, Subramanian S, Farmer JC, Ries M, Scott B; Governance Stakeholder Working Group and National Emergency Tele-Critical Care Network Team Participants. Pamplin JC, et al. Among authors: colombo cj. Crit Care Explor. 2024 May 13;6(5):e1091. doi: 10.1097/CCE.0000000000001091. eCollection 2024 May. Crit Care Explor. 2024. PMID: 38746740 Free PMC article.
[Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
Campagna G, Amato A, Majo F, Ferrari G, Quattrucci S, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M; Gruppo di lavoro RIFC. Campagna G, et al. Epidemiol Prev. 2024 Mar-Apr;48(2 Suppl 2):1-41. doi: 10.19191/EP24.2.S2.031. Epidemiol Prev. 2024. PMID: 38742380 Italian.
Higher Seasonal Variation of Systemic Inflammation in Bipolar Disorder.
Dallaspezia S, Cardaci V, Mazza MG, De Lorenzo R, Rovere Querini P, Colombo C, Benedetti F. Dallaspezia S, et al. Among authors: colombo c. Int J Mol Sci. 2024 Apr 13;25(8):4310. doi: 10.3390/ijms25084310. Int J Mol Sci. 2024. PMID: 38673894 Free PMC article.
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
1,169 results